tradingkey.logo

Vaxart Inc <VXRT.OQ> expected to post a loss of 10 cents a share - Earnings Preview

ReutersMar 10, 2025 11:07 AM
  • Vaxart Inc VXRT.OQ VXRT.O is expected to show a rise in quarterly revenue when it reports results on March 12 (estimated) for the period ending December 31 2024

  • The South San Francisco California-based company is expected to report a 540.0% increase in revenue to $20.767 million from $3.25 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Vaxart Inc is for a loss of 10 cents per share.

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Vaxart Inc is $4.00​, above​ its last closing price of $0.47. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

-0.11

-0.10

-0.06

Beat

40

Jun. 30 2024

0.01

-0.03

-0.09

Missed

-237.5

Mar. 31 2024

-0.14

-0.14

-0.14

Met

0​

Dec. 31 2023

-0.16

-0.14

-0.12

Beat

17.2

​​Sep. 30 2023

-0.18

-0.18

-0.11

Beat

37.7

Jun. 30 2023

-0.18

-0.18

-0.16

Beat

11.1​

Mar. 31 2023

-0.18

-0.19

-0.19

Met

-1.8

Dec. 31 2022

-0.22

-0.23

-0.18

Beat

20.9

This summary was machine generated March 10 at 11:07 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI